Patents Assigned to SINGULAR IMMUNE, INC.
  • COMPOSITION AND METHOD OF USE RECOMBINANT FUSION PROTEIN TO GENERATE CAR-IMMUNE CELLS
    Publication number: 20250090662
    Abstract: Provided herein are a recombinant chimeric antigen receptor (CAR) fusion protein, a method of modifying an immune cell into a CAR immune cell by treating the immune cell with the recombinant CAR fusion protein, and a method of treating cancer by administering the CAR immune cell to a subject in need thereof.
    Type: Application
    Filed: September 13, 2024
    Publication date: March 20, 2025
    Applicant: SINGULAR IMMUNE, INC.
    Inventors: Youngwook WON, Seungmin HAN, David BULL
  • Composition and method of use recombinant fusion protein to generate CAR-immune cells
    Patent number: 12005082
    Abstract: Provided herein are a recombinant chimeric antigen receptor (CAR) fusion protein, a method of modifying an immune cell into a CAR immune cell by treating the immune cell with the recombinant CAR fusion protein, and a method of treating cancer by administering the CAR immune cell to a subject in need thereof.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: June 11, 2024
    Assignee: SINGULAR IMMUNE, INC.
    Inventors: Youngwook Won, Seungmin Han, David Bull
  • COMPOSITION AND METHOD OF USE RECOMBINANT FUSION PROTEIN TO GENERATE CAR-IMMUNE CELLS
    Publication number: 20230293584
    Abstract: Provided herein are a recombinant chimeric antigen receptor (CAR) fusion protein, a method of modifying an immune cell into a CAR immune cell by treating the immune cell with the recombinant CAR fusion protein, and a method of treating cancer by administering the CAR immune cell to a subject in need thereof.
    Type: Application
    Filed: March 17, 2023
    Publication date: September 21, 2023
    Applicant: SINGULAR IMMUNE, INC.
    Inventors: Youngwook WON, Seungmin HAN, David BULL